Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nrx Pharmaceuticals Inc 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 USA

www.nrxpharma.com P: 484-254-6134

Sector:

Medical

Description:

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 65,723
Enterprise Value, $K 69,613
Shares Outstanding, K 29,605
Annual Sales, $ 0 K
Annual Net Income, $ -25,130 K
Last Quarter Sales, $ 240 K
Last Quarter Net Income, $ -5,890 K
EBIT, $ -15,210 K
EBITDA, $ -15,200 K
60-Month Beta 1.62
% of Insider Shareholders 19.00%
% of Institutional Shareholders 4.27%
Float, K 23,980
% Float 81.00%
Short Interest 1,745
Short Float 5.90%
Short Volume Ratio 0.52

Growth:

1-Year Return -55.77%
3-Year Return -84.14%
5-Year Return -99.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 11/14/25
Next Earnings Date 03/13/26
Earnings Per Share ttm -1.80
EPS Growth vs. Prev Qtr 81.63%
EPS Growth vs. Prev Year -20.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/02/24

NRXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 12.00
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -395.06%
Profit Margin % 0.00%
Debt/Equity -0.39
Price/Sales 158.01
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.93
Interest Coverage -108.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar